AIC T-Hub Healthcare Program Launches 5th Cohort for Startups

Startup incubator T-Hub, in partnership with Atal Innovation Mission (AIM), has introduced the fifth cohort of the AIC T-Hub Healthcare Program. This initiative has selected twenty innovative startups from a competitive field of more than 209 applications.

As outlined by T-Hub, this three-month hybrid program aims to expedite advancements in MedTech, digital health, and healthcare accessibility. It offers startups valuable resources such as mentorship, market access, connections with investors, and guidance on regulatory matters.

Selected Startups in the AIC T-Hub Healthcare Program

The cohort features an array of promising startups including Artyem Care, Bioscafil, Chqup, Cloud Palliative Care, Dag2IL, Epirelief, Dr. DICOM (GLOCAL DIGITAL), Kashi Medicos, Nahush Pharma, Oui Medical, Planytics, Reyansh Technologies, Sigma Mozak, Signel Biomedical, Skinska, Tap Health, thebabyland, TurocratesAI, 365Veda, and Warkas. These enterprises were chosen based on criteria such as proof-of-concept readiness, technological innovation, regulatory compliance, market potential, and the strength of their founding teams.

Program Benefits for Startups

Participating in this program provides startups with unique opportunities to collaborate with leading hospitals and healthcare institutions for real-world validation and pilot studies. This ensures that their solutions are ready for the market and clinically viable. Furthermore, by connecting with venture capitalists, healthcare companies, and policymakers, these startups can build strategic partnerships and obtain necessary funding.

Since its launch, the AIC T-Hub has supported a total of 53 healthcare startups across four previous cohorts, focusing on MedTech, digital health, and healthcare accessibility. These startups have collectively secured funding exceeding Rs 60.46 crore through various investors and grants. They have also facilitated over 180 market access opportunities through collaborations with hospitals, corporates, and healthcare institutions.